King Therapeutics LLC

CIK 2088073 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for King Therapeutics LLC.

Recent SEC filings

FiledFormAccession number
Oct 15, 2025D0002088073-25-000001